Related references
Note: Only part of the references are listed.Drug-Loaded Nanocarriers: Passive Targeting and Crossing of Biological Barriers
J. M. Rabanel et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution
Anne L. van de Ven et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
Sebastien Taurin et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Cancer Therapy: Cooperative, Nanoparticle-Enabled Thermal Therapy of Breast Cancer (Adv. Healthcare Mater. 1/2012)
Haifa Shen et al.
Advanced Healthcare Materials (2012)
Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors
Anne L. van de Ven et al.
AIP ADVANCES (2012)
Multistage Nanovectors: From Concept to Novel Imaging Contrast Agents and Therapeutics
Biana Godin et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Tumor delivery of macromolecular drugs based on the EPR effect
Vladimir Torchilin
ADVANCED DRUG DELIVERY REVIEWS (2011)
E-Selectin-Targeted Porous Silicon Particle for Nanoparticle Delivery to the Bone Marrow
Aman P. Mann et al.
ADVANCED MATERIALS (2011)
Nanomaterials: Applications in Cancer Imaging and Therapy
Jose A. Barreto et al.
ADVANCED MATERIALS (2011)
New aspects of the molecular constituents of tissue barriers
H. C. Bauer et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Nanoparticles that communicate in vivo to amplify tumour targeting
Geoffrey von Maltzahn et al.
NATURE MATERIALS (2011)
The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers
Carlee E. Ashley et al.
NATURE MATERIALS (2011)
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Jin-Wook Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles
Timothy J. Merkel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
What does physics have to do with cancer?
Franziska Michor et al.
NATURE REVIEWS CANCER (2011)
Tailored Porous Silicon Microparticles: Fabrication and Properties
Ciro Chiappini et al.
CHEMPHYSCHEM (2010)
Trastuzumab (Herceptin®): overcoming resistance in HER2-overexpressing breast cancer models
Huguette Albrecht
IMMUNOTHERAPY (2010)
Intracellular trafficking of silicon particles and logic-embedded vectors
Silvia Ferrati et al.
NANOSCALE (2010)
Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast
Jeyarama S. Ananta et al.
NATURE NANOTECHNOLOGY (2010)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Silver Nanoparticle Induced Blood-Brain Barrier Inflammation and Increased Permeability in Primary Rat Brain Microvessel Endothelial Cells
William J. Trickler et al.
TOXICOLOGICAL SCIENCES (2010)
Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Mauro Ferrari
TRENDS IN BIOTECHNOLOGY (2010)
Nanotechnology for breast cancer therapy
Takemi Tanaka et al.
BIOMEDICAL MICRODEVICES (2009)
In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan-doxorubicin conjugates
Young Il Cho et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Mechanisms for transcellular diapedesis: probing and pathfinding by 'invadosome-like protrusions'
Christopher V. Carman
JOURNAL OF CELL SCIENCE (2009)
Mitotic trafficking of silicon microparticles
Rita E. Serda et al.
NANOSCALE (2009)
Physical approaches to biomaterial design
Samir Mitragotri et al.
NATURE MATERIALS (2009)
Multi-targeted therapy of cancer by genistein
Sanjeev Banerjee et al.
CANCER LETTERS (2008)
Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications
Ennio Tasciotti et al.
NATURE NANOTECHNOLOGY (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers
Julie A. Champion et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging
Marianne Manchester et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45
Sandra J. van Vliet et al.
NATURE IMMUNOLOGY (2006)
New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?
Si-Shen Feng
NANOMEDICINE (2006)
Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains
J Millán et al.
NATURE CELL BIOLOGY (2006)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
DE Owens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-α-activated vascular endothelium under flow
L Yang et al.
BLOOD (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes
O Barreiro et al.
JOURNAL OF CELL BIOLOGY (2002)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
